Wells Fargo Maintains Overweight on Dorman Products, Lowers Price Target to $150

Benzinga · 2d ago
Wells Fargo analyst David Lantz maintains Dorman Products (NASDAQ:DORM) with a Overweight and lowers the price target from $160 to $150.